BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7870934)

  • 21. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus properties of eltoprazine in the pigeon.
    Olivier B; Herremans A; Mos J; van Drimmelen M; Tulp M; van Oorschot R; Hijzen T
    Pharmacol Biochem Behav; 1999 Oct; 64(2):421-7. PubMed ID: 10515324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D; Nichols DE
    Behav Pharmacol; 2009 Feb; 20(1):114-8. PubMed ID: 19179855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand.
    McElroy JF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):531-3. PubMed ID: 7916465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.
    Powell KR; Koppelman LF; Holtzman SG
    Behav Pharmacol; 1999 Dec; 10(8):707-16. PubMed ID: 10780285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1993; 110(3):280-6. PubMed ID: 7831420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus characteristics of BMY 14802 in the pigeon.
    Vanecek SA; Essman WD; Taylor DP; Woods JH
    J Pharmacol Exp Ther; 1998 Jan; 284(1):1-9. PubMed ID: 9435153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm.
    Ukai M; Mori E; Kameyama T
    Pharmacol Biochem Behav; 1993 Apr; 44(4):907-11. PubMed ID: 8097045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buspirone blocks the discriminative stimulus effects of apomorphine in monkeys.
    Kamien JB; Woolverton WL
    Pharmacol Biochem Behav; 1990 Jan; 35(1):117-20. PubMed ID: 2315348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
    Ryan CN; Evenden JL; Petterson M
    Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan.
    Ybema CE; Olivier B; Mos J; Tulp MT; Slangen JL
    Eur J Pharmacol; 1994 Apr; 256(2):141-7. PubMed ID: 8050464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.